Century Therapeutics Inc’s recent filing unveils that its President and CEO Pfeiffenberger Brent unloaded Company’s shares for reported $1375.0 on Mar 10 ’25. In the deal valued at $0.61 per share,2,235 shares were sold. As a result of this transaction, Pfeiffenberger Brent now holds 1,190,310 shares worth roughly $0.54 million.
Then, Russotti Gregory sold 2,360 shares, generating $1,451 in total proceeds. Upon selling the shares at $0.61, the insider now owns 272,573 shares.
Before that, Farid Adrienne sold 2,359 shares. Century Therapeutics Inc shares valued at $1,451 were divested by the Chief Operations Officer at a price of $0.61 per share. As a result of the transaction, Farid Adrienne now holds 131,717 shares, worth roughly $59272.65.
Rodman & Renshaw initiated its Century Therapeutics Inc [IPSC] rating to a Buy in a research note published on August 08, 2024; the price target was $6. A number of analysts have revised their coverage, including JP Morgan’s analysts, who decreased its forecast for the stock in late August from “an Overweight” to “a Neutral”. Chardan Capital Markets began covering IPSC with “Buy” recommendation on December 27, 2022. Guggenheim started covering the stock on October 31, 2022. It rated IPSC as “a Buy”.
Price Performance Review of IPSC
On Tuesday, Century Therapeutics Inc [NASDAQ:IPSC] saw its stock fall -5.08% to $0.45. Over the last five days, the stock has lost -18.57%. Century Therapeutics Inc shares have fallen nearly -55.27% since the year began. Nevertheless, the stocks have fallen -89.19% over the past one year. While a 52-week high of $4.43 was reached on 01/08/25, a 52-week low of $0.47 was recorded on 04/01/25. SMA at 50 days reached $0.6910, while 200 days put it at $1.4442.
Levels Of Support And Resistance For IPSC Stock
The 24-hour chart illustrates a support level at 0.4353, which if violated will result in even more drops to 0.4189. On the upside, there is a resistance level at 0.4841. A further resistance level may holdings at 0.5165. The Relative Strength Index (RSI) on the 14-day chart is 24.54, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0726, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 99.70%. Stochastics %K at 7.15% indicates the stock is a buying.
How much short interest is there in Century Therapeutics Inc?
A steep rise in short interest was recorded in Century Therapeutics Inc stocks on 2025-03-14, growing by 0.25 million shares to a total of 3.38 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 3.13 million shares. There was a rise of 7.4%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 10, 2022 when Canaccord Genuity began covering the stock and recommended ‘”a Buy”‘ rating along with a $28 price target.
